APO Research
Talk to an analyst

APO RESEARCH · REPORT

Menopause Hormonal Treatment

Compare research editions
View pricing & licenses

Selected research

Industry Research

Menopause Hormonal Treatment Industry Research Report 2026

22 December 2025121 pages

Choose your research edition.

Industry ResearchMenopause Hormonal Treatment Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Menopause Hormonal Treatment Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Menopause Hormonal Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Menopause Hormonal Treatment Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Menopause Hormonal Treatment Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Menopause Hormonal Treatment market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Menopause Hormonal Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Menopause Hormonal Treatment is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Menopause Hormonal Treatment is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Menopause Hormonal Treatment include Teva Pharmaceutical Industries, Novartis, Novo Nordisk, Merck, Eli Lilly And Company, Pfizer, Bayer, AbbVie and Theramex, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Menopause Hormonal Treatment market in terms of revenue (US$ million) and, where applicable, sales volume (tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/tons) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Menopause Hormonal Treatment Market by Company

Teva Pharmaceutical Industries

Novartis

Novo Nordisk

Merck

Eli Lilly And Company

Pfizer

Bayer

AbbVie

Theramex

Pure Encapsulations, Inc.

Emcure Pharmaceuticals

Cipla

Allergan

Menopause Hormonal Treatment Segment by Type

Table

Patch

Spray

Others

Menopause Hormonal Treatment Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Menopause Hormonal Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Menopause Hormonal Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Menopause Hormonal Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Menopause Hormonal Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Menopause Hormonal Treatment manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Menopause Hormonal Treatment by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Menopause Hormonal Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Menopause Hormonal Treatment Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Menopause Hormonal Treatment Sales (tons) of Manufacturers (2021-2026) Table 7. Global Menopause Hormonal Treatment Sales Market Share by Manufacturers (2021-2026) Table 8. Global Menopause Hormonal Treatment Revenue of Manufacturers (2021-2026) Table 9. Global Menopause Hormonal Treatment Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Menopause Hormonal Treatment Average Price (US$/ton) of Manufacturers (2021-2026) Table 11. Global Menopause Hormonal Treatment Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Menopause Hormonal Treatment, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Menopause Hormonal Treatment, Product Type & Application Table 14. Global Menopause Hormonal Treatment Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Menopause Hormonal Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Teva Pharmaceutical Industries Company Information Table 19. Teva Pharmaceutical Industries Business Overview Table 20. Teva Pharmaceutical Industries Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 21. Teva Pharmaceutical Industries Menopause Hormonal Treatment Product Portfolio Table 22. Teva Pharmaceutical Industries Recent Developments Table 23. Novartis Company Information Table 24. Novartis Business Overview Table 25. Novartis Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 26. Novartis Menopause Hormonal Treatment Product Portfolio Table 27. Novartis Recent Developments Table 28. Novo Nordisk Company Information Table 29. Novo Nordisk Business Overview Table 30. Novo Nordisk Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 31. Novo Nordisk Menopause Hormonal Treatment Product Portfolio Table 32. Novo Nordisk Recent Developments Table 33. Merck Company Information Table 34. Merck Business Overview Table 35. Merck Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 36. Merck Menopause Hormonal Treatment Product Portfolio Table 37. Merck Recent Developments Table 38. Eli Lilly And Company Company Information Table 39. Eli Lilly And Company Business Overview Table 40. Eli Lilly And Company Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 41. Eli Lilly And Company Menopause Hormonal Treatment Product Portfolio Table 42. Eli Lilly And Company Recent Developments Table 43. Pfizer Company Information Table 44. Pfizer Business Overview Table 45. Pfizer Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 46. Pfizer Menopause Hormonal Treatment Product Portfolio Table 47. Pfizer Recent Developments Table 48. Bayer Company Information Table 49. Bayer Business Overview Table 50. Bayer Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 51. Bayer Menopause Hormonal Treatment Product Portfolio Table 52. Bayer Recent Developments Table 53. AbbVie Company Information Table 54. AbbVie Business Overview Table 55. AbbVie Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 56. AbbVie Menopause Hormonal Treatment Product Portfolio Table 57. AbbVie Recent Developments Table 58. Theramex Company Information Table 59. Theramex Business Overview Table 60. Theramex Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 61. Theramex Menopause Hormonal Treatment Product Portfolio Table 62. Theramex Recent Developments Table 63. Pure Encapsulations, Inc. Company Information Table 64. Pure Encapsulations, Inc. Business Overview Table 65. Pure Encapsulations, Inc. Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 66. Pure Encapsulations, Inc. Menopause Hormonal Treatment Product Portfolio Table 67. Pure Encapsulations, Inc. Recent Developments Table 68. Emcure Pharmaceuticals Company Information Table 69. Emcure Pharmaceuticals Business Overview Table 70. Emcure Pharmaceuticals Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 71. Emcure Pharmaceuticals Menopause Hormonal Treatment Product Portfolio Table 72. Emcure Pharmaceuticals Recent Developments Table 73. Cipla Company Information Table 74. Cipla Business Overview Table 75. Cipla Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Cipla Menopause Hormonal Treatment Product Portfolio Table 77. Cipla Recent Developments Table 78. Allergan Company Information Table 79. Allergan Business Overview Table 80. Allergan Menopause Hormonal Treatment Sales (tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. Allergan Menopause Hormonal Treatment Product Portfolio Table 82. Allergan Recent Developments Table 83. Global Menopause Hormonal Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 84. Global Menopause Hormonal Treatment Sales by Region (2021-2026) & (tons) Table 85. Global Menopause Hormonal Treatment Sales Market Share by Region (2021-2026) Table 86. Global Menopause Hormonal Treatment Sales by Region (2027-2032) & (tons) Table 87. Global Menopause Hormonal Treatment Sales Market Share by Region (2027-2032) Table 88. Global Menopause Hormonal Treatment Revenue by Region (2021-2026) & (US$ Million) Table 89. Global Menopause Hormonal Treatment Revenue Market Share by Region (2021-2026) Table 90. Global Menopause Hormonal Treatment Revenue by Region (2027-2032) & (US$ Million) Table 91. Global Menopause Hormonal Treatment Revenue Market Share by Region (2027-2032) Table 92. North America Menopause Hormonal Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. North America Menopause Hormonal Treatment Sales by Country (2021-2026) & (tons) Table 94. North America Menopause Hormonal Treatment Sales by Country (2027-2032) & (tons) Table 95. North America Menopause Hormonal Treatment Revenue by Country (2021-2026) & (US$ Million) Table 96. North America Menopause Hormonal Treatment Revenue by Country (2027-2032) & (US$ Million) Table 97. Europe Menopause Hormonal Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Europe Menopause Hormonal Treatment Sales by Country (2021-2026) & (tons) Table 99. Europe Menopause Hormonal Treatment Sales by Country (2027-2032) & (tons) Table 100. Europe Menopause Hormonal Treatment Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Menopause Hormonal Treatment Revenue by Country (2027-2032) & (US$ Million) Table 102. Asia Pacific Menopause Hormonal Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Asia Pacific Menopause Hormonal Treatment Sales by Country (2021-2026) & (tons) Table 104. Asia Pacific Menopause Hormonal Treatment Sales by Country (2027-2032) & (tons) Table 105. Asia Pacific Menopause Hormonal Treatment Revenue by Country (2021-2026) & (US$ Million) Table 106. Asia Pacific Menopause Hormonal Treatment Revenue by Country (2027-2032) & (US$ Million) Table 107. South America Menopause Hormonal Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. South America Menopause Hormonal Treatment Sales by Country (2021-2026) & (tons) Table 109. South America Menopause Hormonal Treatment Sales by Country (2027-2032) & (tons) Table 110. South America Menopause Hormonal Treatment Revenue by Country (2021-2026) & (US$ Million) Table 111. South America Menopause Hormonal Treatment Revenue by Country (2027-2032) & (US$ Million) Table 112. Middle East and Africa Menopause Hormonal Treatment Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Middle East and Africa Menopause Hormonal Treatment Sales by Country (2021-2026) & (tons) Table 114. Middle East and Africa Menopause Hormonal Treatment Sales by Country (2027-2032) & (tons) Table 115. Middle East and Africa Menopause Hormonal Treatment Revenue by Country (2021-2026) & (US$ Million) Table 116. Middle East and Africa Menopause Hormonal Treatment Revenue by Country (2027-2032) & (US$ Million) Table 117. Global Menopause Hormonal Treatment Sales by Type (2021-2026) & (tons) Table 118. Global Menopause Hormonal Treatment Sales by Type (2027-2032) & (tons) Table 119. Global Menopause Hormonal Treatment Sales Market Share by Type (2021-2026) Table 120. Global Menopause Hormonal Treatment Sales Market Share by Type (2027-2032) Table 121. Global Menopause Hormonal Treatment Revenue by Type (2021-2026) & (US$ Million) Table 122. Global Menopause Hormonal Treatment Revenue by Type (2027-2032) & (US$ Million) Table 123. Global Menopause Hormonal Treatment Revenue Market Share by Type (2021-2026) Table 124. Global Menopause Hormonal Treatment Revenue Market Share by Type (2027-2032) Table 125. Global Menopause Hormonal Treatment Price by Type (2021-2026) & (US$/ton) Table 126. Global Menopause Hormonal Treatment Price by Type (2027-2032) & (US$/ton) Table 127. Global Menopause Hormonal Treatment Sales by Application (2021-2026) & (tons) Table 128. Global Menopause Hormonal Treatment Sales by Application (2027-2032) & (tons) Table 129. Global Menopause Hormonal Treatment Sales Market Share by Application (2021-2026) Table 130. Global Menopause Hormonal Treatment Sales Market Share by Application (2027-2032) Table 131. Global Menopause Hormonal Treatment Revenue by Application (2021-2026) & (US$ Million) Table 132. Global Menopause Hormonal Treatment Revenue by Application (2027-2032) & (US$ Million) Table 133. Global Menopause Hormonal Treatment Revenue Market Share by Application (2021-2026) Table 134. Global Menopause Hormonal Treatment Revenue Market Share by Application (2027-2032) Table 135. Global Menopause Hormonal Treatment Price by Application (2021-2026) & (US$/ton) Table 136. Global Menopause Hormonal Treatment Price by Application (2027-2032) & (US$/ton) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Menopause Hormonal Treatment Distributors List Table 140. Menopause Hormonal Treatment Customers List Table 141. Menopause Hormonal Treatment Industry Trends Table 142. Menopause Hormonal Treatment Industry Drivers Table 143. Menopause Hormonal Treatment Industry Restraints Table 144. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Menopause Hormonal Treatment Product Image Figure 5. Global Menopause Hormonal Treatment Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Menopause Hormonal Treatment Market Size (2021-2032) & (US$ Million) Figure 7. Global Menopause Hormonal Treatment Sales (2021-2032) & (tons) Figure 8. Global Menopause Hormonal Treatment Average Price (US$/ton) & (2021-2032) Figure 9. Table Product Image Figure 10. Patch Product Image Figure 11. Spray Product Image Figure 12. Others Product Image Figure 13. Retail Pharmacies Product Image Figure 14. Online Pharmacies Product Image Figure 15. Hospital Pharmacies Product Image Figure 16. Global Menopause Hormonal Treatment Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Menopause Hormonal Treatment, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Menopause Hormonal Treatment Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Menopause Hormonal Treatment Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Menopause Hormonal Treatment Sales by Region in 2025 Figure 22. Global Menopause Hormonal Treatment Revenue by Region in 2025 Figure 23. North America Menopause Hormonal Treatment Market Size by Country in 2025 Figure 24. North America Menopause Hormonal Treatment Sales Market Share by Country (2021-2032) Figure 25. North America Menopause Hormonal Treatment Revenue Market Share by Country (2021-2032) Figure 26. United States Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Menopause Hormonal Treatment Market Size by Country in 2025 Figure 30. Europe Menopause Hormonal Treatment Sales Market Share by Country (2021-2032) Figure 31. Europe Menopause Hormonal Treatment Revenue Market Share by Country (2021-2032) Figure 32. Germany Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Menopause Hormonal Treatment Market Size by Country in 2025 Figure 43. Asia Pacific Menopause Hormonal Treatment Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Menopause Hormonal Treatment Revenue Market Share by Country (2021-2032) Figure 45. China Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Menopause Hormonal Treatment Market Size by Country in 2025 Figure 54. South America Menopause Hormonal Treatment Sales Market Share by Country (2021-2032) Figure 55. South America Menopause Hormonal Treatment Revenue Market Share by Country (2021-2032) Figure 56. Brazil Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Menopause Hormonal Treatment Market Size by Country in 2025 Figure 60. Middle East and Africa Menopause Hormonal Treatment Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Menopause Hormonal Treatment Revenue Market Share by Country (2021-2032) Figure 62. Egypt Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Menopause Hormonal Treatment Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Menopause Hormonal Treatment Sales Market Share by Type (2021-2032) Figure 68. Global Menopause Hormonal Treatment Revenue Market Share by Type (2021-2032) Figure 69. Global Menopause Hormonal Treatment Price (US$/ton) by Type (2021-2032) Figure 70. Global Menopause Hormonal Treatment Sales Market Share by Application (2021-2032) Figure 71. Global Menopause Hormonal Treatment Revenue Market Share by Application (2021-2032) Figure 72. Global Menopause Hormonal Treatment Price (US$/ton) by Application (2021-2032) Figure 73. Menopause Hormonal Treatment Value Chain Figure 74. Menopause Hormonal Treatment Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Menopause Hormonal Treatment Industry Opportunities and Challenges

Scope & coverage.

Types
  • Table
  • Patch
  • Spray
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
Companies covered
  • Teva Pharmaceutical Industries
  • Novartis
  • Novo Nordisk
  • Merck
  • Eli Lilly And Company
  • Pfizer
  • Bayer
  • AbbVie
  • Theramex
  • Pure Encapsulations, Inc.
  • Emcure Pharmaceuticals
  • Cipla
  • Allergan

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Menopause Hormonal Treatment Market Size (2021-2032)
  4. 2.2.2 Global Menopause Hormonal Treatment Sales (2021-2032)
  5. 2.2.3 Global Menopause Hormonal Treatment Market Average Price (2021-2032)
  6. 2.3 Menopause Hormonal Treatment by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Table
  9. 2.3.3 Patch
  10. 2.3.4 Spray
  11. 2.3.5 Others
  12. 2.4 Menopause Hormonal Treatment by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Retail Pharmacies
  15. 2.4.3 Online Pharmacies
  16. 2.4.4 Hospital Pharmacies
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Menopause Hormonal Treatment Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Menopause Hormonal Treatment Sales (tons) of Manufacturers (2021-2026)
  3. 3.3 Global Menopause Hormonal Treatment Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Menopause Hormonal Treatment Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Menopause Hormonal Treatment Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Menopause Hormonal Treatment, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Menopause Hormonal Treatment, Product Type & Application
  8. 3.8 Global Manufacturers of Menopause Hormonal Treatment, Established Date
  9. 3.9 Global Menopause Hormonal Treatment Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Teva Pharmaceutical Industries
  2. 4.1.1 Teva Pharmaceutical Industries Company Information
  3. 4.1.2 Teva Pharmaceutical Industries Business Overview
  4. 4.1.3 Teva Pharmaceutical Industries Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Teva Pharmaceutical Industries Menopause Hormonal Treatment Product Portfolio
  6. 4.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 4.2 Novartis
  8. 4.2.1 Novartis Company Information
  9. 4.2.2 Novartis Business Overview
  10. 4.2.3 Novartis Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Novartis Menopause Hormonal Treatment Product Portfolio
  12. 4.2.5 Novartis Recent Developments
  13. 4.3 Novo Nordisk
  14. 4.3.1 Novo Nordisk Company Information
  15. 4.3.2 Novo Nordisk Business Overview
  16. 4.3.3 Novo Nordisk Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Novo Nordisk Menopause Hormonal Treatment Product Portfolio
  18. 4.3.5 Novo Nordisk Recent Developments
  19. 4.4 Merck
  20. 4.4.1 Merck Company Information
  21. 4.4.2 Merck Business Overview
  22. 4.4.3 Merck Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Merck Menopause Hormonal Treatment Product Portfolio
  24. 4.4.5 Merck Recent Developments
  25. 4.5 Eli Lilly And Company
  26. 4.5.1 Eli Lilly And Company Company Information
  27. 4.5.2 Eli Lilly And Company Business Overview
  28. 4.5.3 Eli Lilly And Company Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Eli Lilly And Company Menopause Hormonal Treatment Product Portfolio
  30. 4.5.5 Eli Lilly And Company Recent Developments
  31. 4.6 Pfizer
  32. 4.6.1 Pfizer Company Information
  33. 4.6.2 Pfizer Business Overview
  34. 4.6.3 Pfizer Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Pfizer Menopause Hormonal Treatment Product Portfolio
  36. 4.6.5 Pfizer Recent Developments
  37. 4.7 Bayer
  38. 4.7.1 Bayer Company Information
  39. 4.7.2 Bayer Business Overview
  40. 4.7.3 Bayer Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Bayer Menopause Hormonal Treatment Product Portfolio
  42. 4.7.5 Bayer Recent Developments
  43. 4.8 AbbVie
  44. 4.8.1 AbbVie Company Information
  45. 4.8.2 AbbVie Business Overview
  46. 4.8.3 AbbVie Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 AbbVie Menopause Hormonal Treatment Product Portfolio
  48. 4.8.5 AbbVie Recent Developments
  49. 4.9 Theramex
  50. 4.9.1 Theramex Company Information
  51. 4.9.2 Theramex Business Overview
  52. 4.9.3 Theramex Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Theramex Menopause Hormonal Treatment Product Portfolio
  54. 4.9.5 Theramex Recent Developments
  55. 4.10 Pure Encapsulations, Inc.
  56. 4.10.1 Pure Encapsulations, Inc. Company Information
  57. 4.10.2 Pure Encapsulations, Inc. Business Overview
  58. 4.10.3 Pure Encapsulations, Inc. Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Pure Encapsulations, Inc. Menopause Hormonal Treatment Product Portfolio
  60. 4.10.5 Pure Encapsulations, Inc. Recent Developments
  61. 4.11 Emcure Pharmaceuticals
  62. 4.11.1 Emcure Pharmaceuticals Company Information
  63. 4.11.2 Emcure Pharmaceuticals Business Overview
  64. 4.11.3 Emcure Pharmaceuticals Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Emcure Pharmaceuticals Menopause Hormonal Treatment Product Portfolio
  66. 4.11.5 Emcure Pharmaceuticals Recent Developments
  67. 4.12 Cipla
  68. 4.12.1 Cipla Company Information
  69. 4.12.2 Cipla Business Overview
  70. 4.12.3 Cipla Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Cipla Menopause Hormonal Treatment Product Portfolio
  72. 4.12.5 Cipla Recent Developments
  73. 4.13 Allergan
  74. 4.13.1 Allergan Company Information
  75. 4.13.2 Allergan Business Overview
  76. 4.13.3 Allergan Menopause Hormonal Treatment Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Allergan Menopause Hormonal Treatment Product Portfolio
  78. 4.13.5 Allergan Recent Developments
5 Global Menopause Hormonal Treatment Market Scenario by Region
  1. 5.1 Global Menopause Hormonal Treatment Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Menopause Hormonal Treatment Sales by Region: 2021-2032
  3. 5.2.1 Global Menopause Hormonal Treatment Sales by Region: 2021-2026
  4. 5.2.2 Global Menopause Hormonal Treatment Sales by Region: 2027-2032
  5. 5.3 Global Menopause Hormonal Treatment Revenue by Region: 2021-2032
  6. 5.3.1 Global Menopause Hormonal Treatment Revenue by Region: 2021-2026
  7. 5.3.2 Global Menopause Hormonal Treatment Revenue by Region: 2027-2032
  8. 5.4 North America Menopause Hormonal Treatment Market Facts & Figures by Country
  9. 5.4.1 North America Menopause Hormonal Treatment Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Menopause Hormonal Treatment Sales by Country (2021-2032)
  11. 5.4.3 North America Menopause Hormonal Treatment Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Menopause Hormonal Treatment Market Facts & Figures by Country
  16. 5.5.1 Europe Menopause Hormonal Treatment Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Menopause Hormonal Treatment Sales by Country (2021-2032)
  18. 5.5.3 Europe Menopause Hormonal Treatment Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Menopause Hormonal Treatment Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Menopause Hormonal Treatment Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Menopause Hormonal Treatment Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Menopause Hormonal Treatment Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Menopause Hormonal Treatment Market Facts & Figures by Country
  41. 5.7.1 South America Menopause Hormonal Treatment Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Menopause Hormonal Treatment Sales by Country (2021-2032)
  43. 5.7.3 South America Menopause Hormonal Treatment Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Menopause Hormonal Treatment Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Menopause Hormonal Treatment Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Menopause Hormonal Treatment Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Menopause Hormonal Treatment Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Menopause Hormonal Treatment Sales by Type (2021-2032)
  2. 6.1.1 Global Menopause Hormonal Treatment Sales by Type (2021-2032) & (tons)
  3. 6.1.2 Global Menopause Hormonal Treatment Sales Market Share by Type (2021-2032)
  4. 6.2 Global Menopause Hormonal Treatment Revenue by Type (2021-2032)
  5. 6.2.1 Global Menopause Hormonal Treatment Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Menopause Hormonal Treatment Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Menopause Hormonal Treatment Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Menopause Hormonal Treatment Sales by Application (2021-2032)
  2. 7.1.1 Global Menopause Hormonal Treatment Sales by Application (2021-2032) & (tons)
  3. 7.1.2 Global Menopause Hormonal Treatment Sales Market Share by Application (2021-2032)
  4. 7.2 Global Menopause Hormonal Treatment Revenue by Application (2021-2032)
  5. 7.2.1 Global Menopause Hormonal Treatment Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Menopause Hormonal Treatment Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Menopause Hormonal Treatment Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Menopause Hormonal Treatment Value Chain Analysis
  2. 8.1.1 Menopause Hormonal Treatment Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Menopause Hormonal Treatment Production Mode & Process
  5. 8.2 Menopause Hormonal Treatment Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Menopause Hormonal Treatment Distributors
  8. 8.2.3 Menopause Hormonal Treatment Customers
9 Global Menopause Hormonal Treatment Analyzing Market Dynamics
  1. 9.1 Menopause Hormonal Treatment Industry Trends
  2. 9.2 Menopause Hormonal Treatment Industry Drivers
  3. 9.3 Menopause Hormonal Treatment Industry Opportunities and Challenges
  4. 9.4 Menopause Hormonal Treatment Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst